Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Breast Cancer

  Free Subscription

Articles published in Histopathology

Retrieve available abstracts of 13 articles:
HTML format
Text format

Single Articles

    August 2017
  1. QAISER T, Mukherjee A, Reddy Pb C, Munugoti SD, et al
    Her2 Challenge Contest: A Detailed Assessment of Automated Her2 Scoring Algorithms in Whole Slide Images of Breast Cancer Tissues.
    Histopathology. 2017 Aug 3. doi: 10.1111/his.13333.
    PubMed     Text format     Abstract available

  2. EL ANSARI R, McIntyre A, Craze ML, Ellis IO, et al
    Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
    Histopathology. 2017 Aug 3. doi: 10.1111/his.13334.
    PubMed     Text format     Abstract available

    July 2017
  3. HOLTEN-ROSSING H, Talman MM, Jylling AMB, Laenkholm AV, et al
    Application of automated image analysis reduces the workload of manual screening of sentinel Lymph node biopsies in breast cancer.
    Histopathology. 2017 Jul 5. doi: 10.1111/his.13305.
    PubMed     Text format     Abstract available

    March 2017
  4. POLONIA A, Eloy C, Pinto J, Braga AC, et al
    Counting invasive breast cancer cells in HER2 silver in situ hybridization test: how many cells are enough?
    Histopathology. 2017 Mar 7. doi: 10.1111/his.13208.
    PubMed     Text format     Abstract available

  5. RAKHA EA, Ahmed MA, Aleskandarany MA, Hodi Z, et al
    Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme.
    Histopathology. 2017;70:632-642.
    PubMed     Text format     Abstract available

    November 2016
  6. CHENG KK, Dickson A, Gujam FJ, McMillan DC, et al
    The Relationship between Oestrogen Receptor-alpha Phosphorylation and the Tumour Microenvironment in Patients with Primary Operable Ductal Breast Cancer.
    Histopathology. 2016 Nov 28. doi: 10.1111/his.13134.
    PubMed     Text format     Abstract available

    October 2016
  7. RAKHA EA, Agarwal D, Green AR, Ashankyty I, et al
    Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer.
    Histopathology. 2016 Oct 26. doi: 10.1111/his.13108.
    PubMed     Text format     Abstract available

    July 2016
  8. FOCKE CM, Decker T, van Diest PJ
    Reliability of histological grade in breast cancer core needle biopsies depends on biopsy size: a comparative study with subsequent surgical excisions.
    Histopathology. 2016 Jul 15. doi: 10.1111/his.13036.
    PubMed     Text format     Abstract available

    June 2016
  9. BISERNI GB, Engstrom MJ, Bofin AM
    HER2 gene copy number and breast cancer specific survival.
    Histopathology. 2016 Jun 6. doi: 10.1111/his.13010.
    PubMed     Text format     Abstract available

    May 2016
  10. SAI-GIRIDHAR P, Al-Ramadhani S, George D, Gopinath P, et al
    A multicentre validation of Metasin: a molecular assay for the intraoperative assessment of sentinel lymph nodes from breast cancer patients.
    Histopathology. 2016;68:875-87.
    PubMed     Text format     Abstract available

    March 2016
  11. VAN DORPE J, Hoorens A, Van Roy N, Dedeurwaerdere F, et al
    The challenging differential diagnosis of skin tumours with a rhabdoid phenotype: not all tumours with rhabdoid phenotype belong to the group of SMARCB1-deficient tumours.
    Histopathology. 2016;68:608-12.
    PubMed     Text format    

    January 2016
  12. MAGUIRE A, Brogi E
    Sentinel lymph nodes for breast carcinoma: an update on current practice.
    Histopathology. 2016;68:152-67.
    PubMed     Text format     Abstract available

  13. CALHOUN BC, Collins LC
    Recommendations for excision following core needle biopsy of the breast: a contemporary evaluation of the literature.
    Histopathology. 2016;68:138-51.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.